Integer (ITGR)

Executive Summary

Integer Holdings Corporation (ITGR) is a leading global outsource manufacturer of advanced medical devices and components, serving top OEMs across diverse therapeutic areas including cardiac rhythm management, neuromodulation, vascular access, and orthopedics. The company's vertically integrated, end-to-end capabilities—from design and development to high-volume production—position it as a critical partner in the medtech supply chain. Driven by secular trends of outsourcing and innovation, Integer has demonstrated consistent revenue growth and operational efficiency, with a strong focus on complex, high-value devices that command premium pricing. Its diversified portfolio and blue-chip customer base provide resilience against single-product risk, while ongoing investments in manufacturing capacity and R&D support future expansion. As the medical device industry increasingly relies on specialized partners to reduce time-to-market and manage costs, Integer is well-positioned to capture incremental share, bolstered by its scale, regulatory expertise, and global footprint spanning the US, Ireland, and other regions.

Upcoming Catalysts (preview)

• Q3 2026Q2 2026 Earnings Release90% success
• Q3 2026New multi-year supply agreement with a top-10 medtech OEM50% success
• Q4 2026FDA approval of a key client device manufactured by Integer40% success